Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours
Clinical trial NCT03923842 · UNKNOWN
Trial details
- NCT number
- NCT03923842
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-30
- Primary completion
- 2021-09-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.